Type i interferon plays opposing roles in cytotoxicity and interferon-γ production by natural killer and CD8 T cells after influenza a virus infection in mice

Journal of Innate Immunity

Volumn 6, Issue 4, 2014, Pages 456-466

  Arimori, Yojiro ^a   Nakamura, Risa ^b   Yamada, Hisakata ^a   Shibata, Kensuke ^a   Maeda, Naoyoshi ^c   Kase, Tetsuo ^d   Yoshikai, Yasunobu ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Cytotoxicity; Influenza; Interferon ; Natural killer cell; Type I interferon

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERFERON; ALPHA BETA INTERFERON RECEPTOR; INTERLEUKIN 10;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; 129 MOUSE; ANIMAL; ANTIBODY SPECIFICITY; C57BL MOUSE; CELL CULTURE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; LYMPHOCYTE ACTIVATION; METABOLISM; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIROLOGY; ANIMAL CELL; DOWN REGULATION; EFFECTOR CELL; INFLUENZA A; INTERFERON PRODUCTION; SURVIVAL RATE; T CELL DEPLETION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; INFLUENZA A VIRUS; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-10; KILLER CELLS, NATURAL; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN SPECIFICITY; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84902793251     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000356824     Document Type: Article

References (40)

1. Nakamura R, Maeda N, Shibata K, Yamada H, Kase T, Yoshikai Y: Interleukin-15 is critical in the pathogenesis of influenza A virus-induced acute lung injury. J Virol 2010; 84: 5574-5582.
2. Abdul-Careem MF, Mian MF, Yue G, Gill-grass A, Chenoweth MJ, Barra NG, Chew MV, Chan T, Al-Garawi AA, Jordana M, Ash-kar AA: Critical role of natural killer cells in lung immunopathology during influenza infection in mice. J Infect Dis 2012; 206:167-177.
3. Lettau M, Schmidt H, Kabelitz D, Janssen O: Secretory lysosomes and their cargo in T and NK cells. Immunol Lett 2007; 108:10-19.
4. Billiau A, Matthys P: Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev 2009; 20:97-113.
5. Randall RE, Goodbourn S: Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus counter-measures. J Gen Virol 2008; 89:1-47.
6. Platanias LC: Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol 2005; 5:375-386.
7. Sadler AJ, Williams BR: Interferon-inducible antiviral effectors. Nat Rev Immunol 2008; 8: 559-568.
8. Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, Caligiuri MA, Durbin JE, Biron CA: Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 2002; 169: 4279-4287.
9. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T: IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005; 434:772-777.
10. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K: Type I interfer-ons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 2005; 202: 637-650.
11. Billiau A: Anti-inflammatory properties of type I interferons. Antiviral Res 2006; 71:108-116.
12. Gonzalez-Navajas JM, Lee J, David M, Raz E: Immunomodulatory functions of type I inter-ferons. Nat Rev Immunol 2012; 12:125-135.
13. Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Forster I, Farlik M, Decker T, Du Pasquier RA, Romero P, Tschopp J: Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 2011; 34:213-223.
14. Arimori Y, Nakamura R, Yamada H, Shibata K, Maeda N, Kase T, Yoshikai Y: Type I inter-feron limits influenza virus-induced acute lung injury by regulation of excessive inflammation in mice. Antiviral Res 2013; 99:230-237.
15. Brown EG: Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8. J Virol 1990; 64:4523-4533.
16. Okuno Y, Matsumoto K, Isegawa Y, Ueda S: Protection against the mouse-adapted A/FM/1/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains. J Virol 1994; 68:517-520.
17. Schmitz N, Kurrer M, Bachmann MF, Kopf M: Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J Virol 2005; 79:6441-6448.
18. Imai Y, Kuba K, Neely GG, Yaghubian-Mal-hami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, Holmdahl R, Nicholls J, Jiang C, Binder CJ, Penninger JM: Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008; 133:235-249.
19. Topham DJ, Tripp RA, Doherty PC: CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 1997; 159: 5197-5200.
20. Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, Stevenson PG: Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 1997; 159:105-117.
21. Flynn KJ, Belz GT, Altman JD, Ahmed R, Woodland DL, Doherty PC: Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 1998; 8: 683-691.
22. Nguyen HH, van Ginkel FW, Vu HL, Novak MJ, McGhee JR, Mestecky J: Gamma inter-feron is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice. J Virol 2000; 74:5495-5501.
23. Price GE, Gaszewska-Mastarlarz A, Mosko-phidis D: The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice. J Virol 2000; 74: 3996-4003.
24. Mosser DM, Zhang X: Interleukin-10: new perspectives on an old cytokine. Immunol Rev 2008; 226:205-218.
25. Saraiva M, O'Garra A: The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010; 10:170-181.
26. Wang H, Brown J, Garcia CA, Tang Y, Bena-kanakere MR, Greenway T, Alard P, Kinane DF, Martin M: The role of glycogen synthase kinase 3 in regulating IFN-beta-mediated IL-10 production. J Immunol 2011; 186:675-684.
27. Sun J, Madan R, Karp CL, Braciale TJ: Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 2009; 15:277-284.
28. McKinstry KK, Strutt TM, Buck A, Curtis JD, Dibble JP, Huston G, Tighe M, Hamada H, Sell S, Dutton RW, Swain SL: IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol 2009; 182:7353-7363.
29. Lee CK, Rao DT, Gertner R, Gimeno R, Frey AB, Levy DE: Distinct requirements for IFNs and STAT1 in NK cell function. J Immunol 2000; 165:3571-3577.
30. Kohlmeier JE, Cookenham T, Roberts AD, Miller SC, Woodland DL: Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challenge. Immunity 2010; 33:96-105.
31. Yajima T, Nishimura H, Sad S, Shen H, Ku-wano H, Yoshikai Y: A novel role of IL-15 in early activation of memory CD8+ CTL after reinfection. J Immunol 2005; 174:3590-3597.
32. Fehniger TA, Caligiuri MA: Interleukin 15: biology and relevance to human disease. Blood 2001; 97:14-32.
33. Doherty PC, Turner SJ, Webby RG, Thomas PG: Influenza and the challenge for immunology. Nat Immunol 2006; 7:449-455.
34. Maines TR, Szretter KJ, Perrone L, Belser JA, Bright RA, Zeng H, Tumpey TM, Katz JM: Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev 2008; 225:68-84.
35. Deng R, Lu M, Korteweg C, Gao Z, McNutt MA, Ye J, Zhang T, Gu J: Distinctly different expression of cytokines and chemokines in the lungs of two H5N1 avian influenza patients. J Pathol 2008; 216:328-336.
36. Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N: Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 2000; 156:1951-1959.
37. Szretter KJ, Gangappa S, Lu X, Smith C, Shieh WJ, Zaki SR, Sambhara S, Tumpey TM, Katz JM: Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 2007; 81:2736-2744.
38. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S: Functions of natural killer cells. Nat Immunol 2008; 9:503-510.
39. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, Angelo-santo JM, Laidlaw BJ, Yang CY, Sathaliyawala T, Kubota M, Turner D, Diamond JM, Goldrath AW, Farber DL, Collman RG, Wherry EJ, Artis D: Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011; 12:1045-1054.
40. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE, Dekruyff RH, Umetsu DT: Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011; 12:631-638.